Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (521-530 of 560) with videos related to

Pageof 56
Sort By:
Journal of the National Cancer Institute|May 3, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast CancerJinani Jayasekera, Yisheng Li, Clyde B Schechter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast CancerBryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Radiology|August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Frontiers in Immunology|May 4, 2026
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world studyFrancesco Caraglia, Giuseppe Argenziano, Marcella Scala, et al.
NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.
The Oncologist|May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker StudyRobert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 14, 2004
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]F Conte, G Cappelli, F Casino, et al.
Journal of Oncology|October 30, 2009
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American WomenChristine B Ambrosone, Gregory L Ciupak, Elisa V Bandera, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Cancer Discovery|January 21, 2025
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast CancerRahat Alam, Anna Reva, David G Edwards, et al.
Pageof 56

Showing results (521-530 of 560) with videos related to

Sort By:
Pageof 56
Journal of the National Cancer Institute|May 3, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast CancerJinani Jayasekera, Yisheng Li, Clyde B Schechter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast CancerBryan P Schneider, Fengmin Zhao, Tarah J Ballinger, et al.
Radiology|August 3, 2021
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, et al.
Frontiers in Immunology|May 4, 2026
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world studyFrancesco Caraglia, Giuseppe Argenziano, Marcella Scala, et al.
NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.
The Oncologist|May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker StudyRobert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 14, 2004
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]F Conte, G Cappelli, F Casino, et al.
Journal of Oncology|October 30, 2009
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American WomenChristine B Ambrosone, Gregory L Ciupak, Elisa V Bandera, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Cancer Discovery|January 21, 2025
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast CancerRahat Alam, Anna Reva, David G Edwards, et al.
Pageof 56